Aripiprazole Monotherapy for Maintenance Therapy in Bipolar I Disorder: A 100-Week, Double-Blind Study Versus Placebo
The DOI matches its Crossref record.
Abstract
OBJECTIVE: A 26-week, double-blind, placebo-controlled relapse prevention study of aripiprazole was designed a priori with a prospective, 74-week, double-blind, placebo-controlled extension phase. Efficacy and tolerability of aripiprazole for relapse prevention in bipolar I disorder was, therefore, evaluated for 100 weeks. METHOD: Patients with DSM-IV bipolar I disorder, recent manic or mixed episode, received open-label aripiprazole 15 or 30 mg/day (started at 30 mg/day) for 6 to 18 weeks. Patients achieving stabilization (Young Mania Rating Scale score or= 5% incidence and twice placebo rate) were tremor, akathisia, dry mouth, hypertension, weight gain, vaginitis, abnormal thinking, pharyngitis, and flu syndrome. Mean weight change from baseline to 100 weeks (last observation carried forward) was +0.4 +/- 0.8 kg with aripiprazole and -1.9 +/- 0.8 kg with placebo. CONCLUSIONS: Over a 100-week treatment period, aripiprazole monotherapy was effective for relapse prevention in patients who were initially stabilized on aripiprazole for 6 consecutive weeks, and it maintained a good safety and tolerability profile. CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov identifier NCT00036348.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“aripiprazole oral (level 2)375, 376 or once monthly (level 2)377 is also recommended as a first‐line monotherapy in view of its efficacy in preventing any mood or manic episode as well as its safety/tolerability profile, although it has not been shown to be effective in preventing depression.”
Citations
Cites
Still being checked.
Cited by
Items 201–237 of 237
Aripiprazole: a discussion on its clinical use in mania associated with bipolar I disorder
Fagiolini, A. M., & Maina, G. (2008) · Drugs & Therapy Perspectives · doi:10.2165/00042310-200824070-00001 · Cited by 1
Evidence-based pharmacotherapy of bipolar disorder
Taylor, M. J., & Geddes, J. R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.004 · Cited by 1
Prophylactic treatment in bipolar disorder
Eroğlu, M. Z., Özpoyraz, N., & Tamam, L. (2013) · Journal of Mood Disorders · doi:10.5455/jmood.20131216050528
Aripiprazole in Bipolar Disorder
Nivoli, A., & Vieta, E. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch12
Pharmacotherapy of Bipolar I Disorder: Focus on Aripiprazole
Bastiaens, L. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2238
Advances in the Pharmacotherapy of Bipolar Affective Disorder
Kumar, A., Kamatchi, R., Marzanski, M., & Somashekar, B. (2012) · InTech eBooks · doi:10.5772/30188
Reproduktive Auffälligkeiten bei unmedizierten Frauen mit bipolarer Erkrankung
Schoofs, N. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-17913
Practical Pharmacological Maintenance Treatment of Bipolar Disorder
Swann, A. C. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch24
Effectiveness of aripiprazole in bipolar disorder patients taking complex pharmacotherapy
Ittasakul, P., Srivastava, S., Wang, P. W., Hill, S. J., Childers, M. E., & Ketter, T. A. (2011) · F1000Research · doi:10.7490/f1000research.1218.1
Pharmacological Management of Manic Episodes
Vieta, E. (2013) · doi:10.1007/978-1-908517-94-4_8
Ullah, H., & Khan, M. F. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Recent Progress in the Pharmacotherapy of Bipolar Disorder
Mitchell, P. B., Loo, C. K. A., & Breakspear, M. J. (2009) · Future Neurology · doi:10.2217/fnl.09.18
Place des antipsychotiques atypiques dans le traitement des troubles de l’humeur
Rohmer, G., & Gassiot, A. (2008) · L Encéphale · doi:10.1016/s0013-7006(08)75516-7 · Cited by 1
Cerù, A. (2011) · Quaderni Italiani di Psichiatria · doi:10.1016/j.quip.2011.09.001
Association of antipsychotics and mood stabilizers for treatment of mania
Rossi, A., & Stratta, P. (2012) · Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila
Tratamiento a largo plazo del trastorno bipolar: papel de los antipsicóticos
de Dios, C. (2015) · Psiquiatría Biológica · doi:10.1016/s1134-5934(15)30009-9
Ittasakul, P., Miller, S., Wang, P. W., Hill, S. J., Childers, M. E., & Ketter, T. A. (2013) · Asian Biomedicine · doi:10.5372/abm.v7i4.1983
Turner, N., Macfadden, W., Anand, R., Khanna, S., Rapaport, M. H., Haskins, J. T., Turkoz, I., & Alphs, L. D. (2011) · PubMed Central · Cited by 1
Akutbehandlung manischer Episoden
Berger, M., Lewitzka, U., & Seemüller, F. (2015) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-015-0845-y
Meist lebenslange Rezidivprophylaxe erforderlich: Bipolare Manie
Messer, T., Tiltscher, C., & Schmauß, M. (2012) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-012-0496-1
Kumar, P. S., Basak, S. C., & Sitty, M. B. (2017) · International Journal of Research in Ayurveda and Pharmacy · doi:10.7897/2277-4343.082124
Welton, R. S., & Roman, B. J. B. (2017) · Wiley eBooks · doi:10.1002/9781119152606.ch4
Bipolare Störungen (ICD-10 F3)
Schläpfer, T. E., WINKLER, R., Greil, W., & GIERSCH, D. (2007) · Elsevier eBooks · doi:10.1016/b978-343724131-4.50013-5
Are (Some) Antipsychotics Depressogenic in Bipolar Disorder?
Goldberg, J. F. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20com13284 · Cited by 1
Guidelines on Mood Stabilizers
Gfesser, J., & Kittel‐Schneider, S. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_117-1
A Naturalistic Study of Outcomes for Durable Remission in Patients With Bipolar Disorder
RAPPORT, D. J., McGrady, A. V., Saju, L., & Lynch, D. J. (2021) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000530
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg002
Chen, G., Machado‐Vieira, R., Zarate, C. A., & Manji, H. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-57401-7_10033
Denko, T., & Thase, M. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09757-2_24
Chen, G., Machado‐Vieira, R., Zarate, C. A., & Manji, H. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-21573-6_10033-1
Guidelines on Mood Stabilizers
Gfesser, J., & Kittel‐Schneider, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_117
Cetkovich, M., Abadi, A. F., Camino, S., Bonetto, G. G., Herbst, L., Marengo, E., Torrente, F. M., Maresca, T., Bustin, J., Morra, C. A., et al. (2023) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i159.363
Prioritizing the Components of Any Decision-Making Model
Goldberg, J. F., & Stahl, S. M. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009181549.012
Revisiting cariprazine for bipolar I disorder maintenance treatment
Price, M. Z., & Price, R. L. (2024) · Bipolar Disorders · doi:10.1111/bdi.13453
Tratamento de prevenção secundária
Dantas, G. V. S., Fernandes, F. N., & Miranda‐Scippa, Â. (2011) · Debates em Psiquiatria · doi:10.25118/2763-9037.2011.v1.1430 · Cited by 1
Antipsychotic medications in affective disorders
Vázquez, G. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33580-8.00009-x
Citrome, L., Zhang, Z., Walker, A. M. H., Atkins, N., & Lynum, K. S. B. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122190
Metadata
- Authors
- Keck, P. E., & Calabrese, J. R.
- Affiliations
- University of Cincinnati (US)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-10-15
- Volume
- 68
- Issue
- 10
- Pages
- 1480-1491
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2087458061
- Cited by
- 238
- References
- 0
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 9 · 2020: 7 · 2019: 7 · 2018: 8 · 2017: 11 · 2016: 8 · 2015: 10 · 2014: 8 · 2013: 17 · 2012: 25
- FWCI
- 14.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- aripiprazole, bipolar I disorder, relapse prevention, maintenance therapy, monotherapy, manic episodes, mixed states, Young Mania Rating Scale, tolerability, adverse effects, weight change
- MeSH terms
- Aripiprazole, Adult, Bipolar Disorder, Depression, Double-Blind Method, Drug Administration Schedule, Female, Humans, Lorazepam, Male, Piperazines, Prospective Studies, Surveys and Questionnaires, Remission Induction, Severity of Illness Index, Antipsychotic Agents, Quinolones, Prevalence, GABA Modulators, Diagnostic and Statistical Manual of Mental Disorders, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.